Dr. Tod Klingler recently joined Genomic Life to head product development and marketing.
Over his 25-year career, Dr. Klingler has held leadership roles with organizations that have successfully developed and commercialized innovative products that advance the understanding of biology and improve human health such as Illumina, Roche, XDx (now CareDx) and Incyte. Applying his expertise in advanced genomic and informatics technologies, Dr. Klingler has also founded start-up companies such as Prospect Genomics and Station X.
Dr. Klingler received his undergraduate degrees and PhD from Stanford University.
Tod is passionate about combining genomics with information to improve human health and propelling organizations forward to deliver on that mission.